Cambridge Healthtech Institute’s Inaugural

Regenerative Medicine
( 再生医疗 )

2018年9月25日

Regenerative medicine hopes to protect, replace or engineer human cells to restore diseased tissues back to a healthy homeostasis. By using stem cells, engineered biomaterials and gene editing approaches, labs around the world are  fighting the rise of chronic and degenerative diseases. Cambridge Healthtech Institute’s Inaugural Regenerative Medicine symposium will focus on the latest tools, targets and platforms.

 

Who should attend: SCIENTISTS, ENGINEERS, CLINICIANS and INDUSTRY LEADERS who work with regenerative medicine or tissue engineering

 

Coverage will include, but is not limited to:                                        

  • Advancing organoid technology toward regenerative medicine
  • Secreted factors (extracellular vesicles, exosomes, etc.) for tissue repair
  • Multi-modal approaches for restoration of cells
  • Regulatory considerations for stem cell-based product development
  • Bioprinting of tissue using human induced pluripotent stem cell
  • Epigenetic modifications, especially affecting molecular phenotype and functionality of cells
  • Evaluation and optimization of preclinical models
  • Strategies for targeting for chronic diseases, reopening the “window of molecular opportunity”

* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English





免费电子邮件通知服务